Abstract:
본 발명은 낙석등 건조 추출물의 에틸아세테이트 분획물을 유효성분으로 함유하는 염증성 질환 치료 및 예방용 약제학적 조성물 및 이의 제조방법에 관한 것으로서, 더욱 상세하게는 낙석등 건조 추출물의 에틸아세테이트 분획물(partition)로서, 지표물질인 악티제닌이 0.05~12 중량%가 함유되도록 정제 및 농축한 추출물을 유효성분으로 함유하는 염증성 질환 예방 및 치료용 조성물과 상기 분획물의 제조방법에 관한 것이다. 낙석등, 추출, 에틸아세테이트, 분획물, 염증성 질환 예방 및 치료
Abstract:
PURPOSE: A pharmaceutical composition containing ethylacetate fraction of Trachelospermi caulis dry extract is provided to ensure improved anti-inflammation effect and use in preventing and treating inflammatory diseases. CONSTITUTION: A composition for preventing and treating inflammatory disease contains ethylacetate fraction of Trachelospermi caulis dry extract. The Trachelospermi caulis dry extract contains 0.05-12 weight% of arctigenin. The Trachelospermi caulis dry extract is obtained by extracting with methanol or ethanol. The ethylacetate fraction of the Trachelospermi caulis dry extract contains 6-20 weight% of arctigenin. A method for producing the ethylacetate fraction comprises: a step of dissolving Trachelospermi caulis dry extract and mixing ethylacetate in dissolved solution to separate water and ethylacetate; a step of collecting ethylacetate layer; and a step of removing solvent from the ethylacetate layer and concentrating to contain 0.05-12 weight% of arctigenin content.